Skip to Main Content

Paper Details

Genomic Aberrations and Late Recurrence in Postmenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the SOLE Trial.
Clin Cancer Res
6
2021
CCND1, CCND1, ERBB2, and MYC CNGs, CNGs, ERBB2, FGFR1, FGFR1 CNG, Hormone Receptor, Hormone Receptor-positive Early Breast Cancer, Ki-67, Letrozole, MYC, PIK3CA, PIK3CA mutations, Women, breast cancer, breast cancers, early breast cancer, early breast cancers, hormone, patients, tumor, women
Author NameAffiliation
Stefan AebiLucerne Cantonal Hospital and University of Bern
Jacquie ChirgwinBox Hill and Maroondah Hospitals, Monash University
Bettina Müller
Meredith M ReganDana-Farber Cancer Institute, and Harvard Medical School
  • 1 - 4

Datasets

Release 1.2